Pavlos Msaouel

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Pavlos Msaouel
Apr 30, 2025, 15:03 | Blog
Posts Not to Miss from AACR 2025: Part 3
The AACR Annual Meeting is one of the biggest events in the world of cancer…
Apr 6, 2025, 12:55 | Opinion
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared an article by Avital M.…
Apr 1, 2025, 11:05 | Insight
IMvigor210 and IMvigor211 - analysis of individual participant data by Alberto Martini
Alberto Martini, Director of Research in the Division of Urology at University of Cincinnati,  shared…
Mar 19, 2025, 12:58 | Blog
Pavlos Msaouel: CA-125 as a Biomarker in Renal Medullary Carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, posted on…
Feb 27, 2025, 13:05 | Blog
Yüksel Ürün: New study shows CA-125 as a potential biomarker for RMC
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on…
Feb 26, 2025, 06:49 | Insight
Pavlos Msaouel: Serum CA-125 as a biomarker for Renal Medullary Carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a post…
Feb 19, 2025, 16:42 | Blog
Dana-Farber Lank Center for Genitourinary Oncology Research Digest
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "GU Research Digest for…
Feb 16, 2025, 04:20 | Societies
Highlights From Day 3 of ASCOGU25
The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society of Clinical…
Feb 13, 2025, 10:22 | Blog
Mohammad Jad Moussa: Overview of our abstracts for ASCO GU 2025
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:…
Feb 1, 2025, 14:47 | Insight
MD Anderson Cancer Center's Research Highlights
Featuring novel treatment strategies for lymphomas and kidney cancers, insights into inflammatory pain, and promising…
Jan 23, 2025, 15:52 | Science
Pavlos Msaouel: Extreme and unexpected phenotypic plasticity by RMC during EZH2 inhibition
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Jan 21, 2025, 15:32 | Science
Mohammad Jad Moussa: What drives post-surgical relapse in SCNEC of the Urinary Tract
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, posted on X about recent…
Jan 20, 2025, 16:30 | Insight
Susanna F. Greer: Outsmarting Kidney Cancer - A New Triple Therapy Approach
Susanna F. Greer, Chief Scientific Officer at The V Foundation for Cancer Research and Leading…
Jan 15, 2025, 05:16 | Blog
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Enrique Grande shared on X: "Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal…
Jan 12, 2025, 17:21 | Insight
Renee Maria Saliby: Immunogenomic determinants of exceptional response to ICI in renal cell carcinoma
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared on X: “Excited to share our…
Jan 12, 2025, 16:35 | Science
Pavlos Msaouel: Sitravatinib with nivolumab and ipilimumab in advanced clear cell renal cell carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, posted on…
Dec 24, 2024, 23:29 | Insight
Mark Bolton: What if patients switch treatment at progression
Mark Bolton, Radiation Oncologist, shared a post on X, about a paper by Amani Al…
Dec 23, 2024, 13:21 | Insight
Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer
Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…
Dec 22, 2024, 11:44 | Insight
Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:…
Dec 19, 2024, 14:08 | Blog
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…
Nov 12, 2024, 18:01 | Blog
Sitravatinib/Ipi/Niv as first line treatment for advanced RCC
Qian Janie Qin, Assistant Professor at UT Southwestern Medical Center, shared a recent article by…
Nov 10, 2024, 17:57 | Insight
Sumanta K. Pal: Richard Schilsky, kicks off the Kidney Cancer Mentorship Academy
Sumanta K. Pal, Medical oncologist at City of Hope, shared on X: “Amazing to have…
Nov 9, 2024, 10:58 | Blog
Pavlos Msaouel: Methodological challenges and solutions in estimating os from Randomized Controlled Trials
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Nov 2, 2024, 20:51 | Insight
Daniel Shapiro: Our editorial regarding perioperative trials in RCC
Daniel Shapiro, Urologic Oncologist at UW Urology, shared a post on X by Pavlos Msaouel,…
Nov 2, 2024, 12:42 | Insight
Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer
Pavlos Msaouel, Assistant Professor at MD Anderson Cancer Center, shared a post on X: "Commentary…
Oct 19, 2024, 02:56 | Insight
Pavlos Msaouel: Our fourth clinical trial designed for Renal Medullary Carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Oct 15, 2024, 12:01 | Insight
Treatment strategies for renal medullary carcinoma and epithelioid sarcoma
Pavlos Msaouel, Oncologist in Houston, University of Texas, shared a post by Ravin Ratan, Associate…
Oct 7, 2024, 07:05 | Insight
Andrew W Hahn: How effective and tolerable is Belzutifan in treating Sporadic Metastatic Clear Cell Renal Cell Carcinoma
Andrew W Hahn, Genitourinary Medical Oncologist, MD Anderson Cancer Center, shared a post on X:…
Sep 24, 2024, 09:18 | Blog
María Natalia Gandur Quiroga: Upfront vs. Deferred Cytoreductive Nephrectomy in mRCC
María Natalia Gandur Quiroga posted on X about recent paper by Stepan M. Esagian et…
Sep 21, 2024, 19:20 | Insight
Pavlos Msaouel: Identifying the biological hallmarks of rare cancers
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Aug 21, 2024, 20:18 | Blog
Pavlos Msaouel: This Renal Medullary Carcinoma research is the highlight of all our milestones
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a…
Aug 12, 2024, 13:28 | Positive
Pavlos Msaouel: The second Msaouel Lab R01 proposal has been funded to investigate Renal Medullary Carcinoma
Pavlos Msaouel, Physician-Scientist at Msaouel Lab, shared on X: "The second Msaouel Lab R01 proposal…
Aug 3, 2024, 09:57 | Blog
Pavlos Msaouel: Exceptions prove the rule and teach us greatly
COA (Chromophobe and Oncocytic Tumor Alliance) shared a post on X, about recent paper published…
Aug 1, 2024, 07:13 | Blog
Pavlos Msaouel: A favorite milestone our research has accomplished for Renal Medullary Carcinoma
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared on X:…
Jul 23, 2024, 07:50 | Blog
Andy Hahn: Body composition’s influence on the therapeutic index with ARSI
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X: "Tweetorial for our…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jul 15, 2024, 07:42 | Blog
KCRS24 Biotech Showcase - KidneyCAN
KidneyCAN shared a post on X:   . "KCRS24 Biotech Showcase. Casdatifan (AB521), Dimitry Nuyten SRK-181…
Jun 29, 2024, 15:06 | Insight
Pavlos Msaouel: Excited for the synergies with The V Foundation, Rare Cancer Research Foundation and Pattern.org to accelerate rare cancer discoveries
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a…
May 30, 2024, 03:50 | Blog
Pavlos Msaouel: Tremendously enjoyed this podcast as the clip shows
Amanda Nizam, GU Medical Oncologist at Cleveland Clinic, shared a post by Pavlos Msaouel, Medical…
May 27, 2024, 05:56 | Blog
Pavlos Msaouel: Grateful to know and follow Jad Chahoud
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a post…
May 16, 2024, 08:20 | Blog
Conquer Cancer, the ASCO Foundation - How is Dr. Pavlos Msaouel conquering cancer?
Conquer Cancer, the ASCO Foundation shared a post on X: "How is Dr. Pavlos Msaouel conquering…
May 5, 2024, 07:31 | Blog
Pavlos Msaouel: Interpreting randomized controlled trials
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a…
Apr 15, 2024, 13:34 | Insight
New Paper Alert! Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall Survival Estimates
Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall…
Apr 15, 2024, 13:08 | Blog
Matt Campbell: Greatly enjoyed taking part in the Translational and Basic Science section at UTCGW24
Matt Campbell, Genitourinary Medical Oncologist at UT MD Anderson Cancer Center, shared a post on…
Apr 11, 2024, 17:35 | Insight
Pavlos Msaouel: So proud of mentee Xinmiao Yan for receiving an AACR Scholar in Training Award
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a…
Mar 12, 2024, 15:30 | Insight
Pavlos Msaouel: This multimodal approach has rendered disease-free previously thought to be incurable in the 2+ line setting
Pavlos Msaouel, Medical Oncologist at GU Department of MD Anderson Cancer Center, shared a post…
Jan 5, 2024, 14:54 | Blog
Pavlos Msaouel: Six papers that improved our understanding of Renal Medullary Carcinoma
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, recently posted…
Jan 3, 2024, 17:23 | Blog
Daniel Mark: Pavlos Msaouel raises critical questions
Daniel Mark, Radiation Oncologist at West Palm Beach, shared a post by Pavlos Msaouel, an…
Nov 15, 2023, 17:32 | Insight
Omar Alhalabi: Have you treated bladder cancer with a component of "neuroendocrine" or "small cell" carcinoma?
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, posted on Twitter. "Have you…
Sep 24, 2023, 22:12 | Insight
Pavlos Msaouel: Just published our review on how to interpret RCTs focusing on key concepts.
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, made the…
All: 50 Posts: 1 - 100
Special Coverage